Hanmi Selects Medidata Cloud Technology

Article

Medidata has signed a multi-year deal with South Koreas Hanmi Pharmaceuticals.

Medidata has signed a multi-year deal with South Korea's Hanmi Pharmaceuticals. The Seoul-based company is adopting Medidatas Clinical Cloud platform into all clinical trials across its drug development programs.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.